Brief: Sprint Bioscience: Petra Pharma Applies For Three Patents For PIP4K2
Jan 23 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* PETRA PHARMA CORPORATION APPLIES FOR THREE PATENTS FOR
CANCER
PROJECT PIP4K2
Source text for Eikon: ID:nWkr6g7K24
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln